• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建叶酸修饰的氟脂质体用于依拉司丁的口服递送以实现靶向抗肿瘤治疗。

Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy.

作者信息

Hong Min, Liu Xiaoyan, Ji Qinghong, Ou Mengyao, Yue Qiaoli, Cheng Shuang

机构信息

School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng, 252059, China.

School of Agricultural Science and Engineering, Liaocheng University, Liaocheng, 252059, China.

出版信息

Drug Deliv Transl Res. 2025 Jan 3. doi: 10.1007/s13346-024-01783-8.

DOI:10.1007/s13346-024-01783-8
PMID:39754000
Abstract

Erastin, as an effective ferroptosis inducer, has received extensive attention in anti-tumor research. To develop an oral nanocarrier for high efficient loading hydrophobic erastin, here we prepared a fluoro-liposome (FA-3 F-LS) by the self-assembly of the folic acid modified fluorinated amphiphiles-FA-3 F conjugates. The hydrophobic component of three perfluorooctyl chains endows the FA-3 F-LSs with high stability to resist the harsh gastrointestinal tract condition. Folic acids conjugated on the surface of FA-3 F-LSs ensure the better tumor targeting and higher oral bioavailability (32.1%) of erastin-loaded FA-3 F-LSs (erastin@FA-3 F-LSs) than free erastin (8.98%). As targeted anti-tumor nanomedicines, erastin@FA-3 F-LSs effectively inhibited the tumor cell proliferation in vitro by inducing ferroptosis through enhancing the glutathione (GSH) depletion, lipid peroxidation and generation of reactive oxygen species. In vivo studies demonstrated that FA-3 F-LSs displayed excellent application potential as a tumor-targeted oral drug delivery nanocarrier to depress the tumor growth with the loaded chemotherapeutic agents.

摘要

埃拉司亭作为一种有效的铁死亡诱导剂,在抗肿瘤研究中受到了广泛关注。为了开发一种用于高效负载疏水性埃拉司亭的口服纳米载体,我们通过叶酸修饰的氟化两亲物-FA-3F共轭物的自组装制备了一种氟脂质体(FA-3F-LS)。三个全氟辛基链的疏水成分赋予FA-3F-LS高稳定性,以抵抗恶劣的胃肠道环境。FA-3F-LS表面偶联的叶酸确保了负载埃拉司亭的FA-3F-LS(埃拉司亭@FA-3F-LS)比游离埃拉司亭(8.98%)具有更好的肿瘤靶向性和更高的口服生物利用度(32.1%)。作为靶向抗肿瘤纳米药物,埃拉司亭@FA-3F-LS通过增强谷胱甘肽(GSH)消耗、脂质过氧化和活性氧的产生诱导铁死亡,从而在体外有效抑制肿瘤细胞增殖。体内研究表明,FA-3F-LS作为一种肿瘤靶向口服给药纳米载体,在负载化疗药物时具有优异的应用潜力,可抑制肿瘤生长。

相似文献

1
Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy.构建叶酸修饰的氟脂质体用于依拉司丁的口服递送以实现靶向抗肿瘤治疗。
Drug Deliv Transl Res. 2025 Jan 3. doi: 10.1007/s13346-024-01783-8.
2
Ginsenoside F2-modified liposomes delivering FTY720 enhance glioblastoma targeting and antitumor activity via ferroptosis.递送FTY720的人参皂苷F2修饰脂质体通过铁死亡增强胶质母细胞瘤靶向性和抗肿瘤活性。
Phytomedicine. 2025 Aug;144:156917. doi: 10.1016/j.phymed.2025.156917. Epub 2025 May 30.
3
Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.靶向细胞外囊泡包裹的 erastin 诱导三阴性乳腺癌细胞发生铁死亡。
Cancer Sci. 2019 Oct;110(10):3173-3182. doi: 10.1111/cas.14181. Epub 2019 Oct 3.
4
Delivery of siGPX4 through a thiol-mediated pathway using a fluorinated cell-penetrating poly(disulfide) for inducing ferroptosis in breast cancer.使用氟化细胞穿透性聚二硫化合物通过硫醇介导的途径递送siGPX4以诱导乳腺癌中的铁死亡。
Acta Biomater. 2025 Jun 15;200:554-568. doi: 10.1016/j.actbio.2025.05.018. Epub 2025 May 21.
5
Melatonin Alleviates Erastin-Induced Cell Death by Inhibiting Ferroptosis and Amyloid Precursor Protein Processing in Neuronal Cell Lines.褪黑素通过抑制神经元细胞系中的铁死亡和淀粉样前体蛋白加工来减轻埃拉斯汀诱导的细胞死亡。
Neurotox Res. 2025 May 30;43(3):25. doi: 10.1007/s12640-025-00747-1.
6
Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1/Nrf2/SLC7A11 signaling pathway.布罗索尤单抗通过调节Keap1/Nrf2/SLC7A11信号通路诱导骨肉瘤细胞发生铁死亡。
Phytomedicine. 2025 Aug;144:156912. doi: 10.1016/j.phymed.2025.156912. Epub 2025 May 30.
7
MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells.叶酸修饰的脂质体负载 MT1DP 通过调控 miR-365a-3p/NRF2 轴增强依维莫司诱导的非小细胞肺癌细胞铁死亡
Cell Death Dis. 2020 Sep 14;11(9):751. doi: 10.1038/s41419-020-02939-3.
8
Carrier-Free Nanomedicine Based on Celastrol and Methotrexate for Synergistic Treatment of Breast Cancer via Folate Targeting.基于雷公藤红素和甲氨蝶呤的无载体纳米药物通过叶酸靶向协同治疗乳腺癌
Int J Nanomedicine. 2025 Jun 27;20:8291-8304. doi: 10.2147/IJN.S516921. eCollection 2025.
9
Construction of Z-Scheme MOF-on-MOF heterostructures for mitochondria-targeted sonodynamic therapy.用于线粒体靶向声动力治疗的Z型MOF-on-MOF异质结构的构建
Acta Biomater. 2025 May 1. doi: 10.1016/j.actbio.2025.05.001.
10
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults.为暴露于砷环境中的儿童和成人提供叶酸以减少砷毒性。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012649. doi: 10.1002/14651858.CD012649.pub2.

本文引用的文献

1
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis.已发表的文献:癌症治疗与诊断中的叶酸受体介导转运体
Chem Sci. 2024 Jan 17;15(6):1966-2006. doi: 10.1039/d3sc05539f. eCollection 2024 Feb 7.
2
Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.基于脂质体载体的癌症治疗响应性药物递送研究进展
Pharmaceutics. 2022 Oct 15;14(10):2195. doi: 10.3390/pharmaceutics14102195.
3
Tumor-targeted hyaluronic acid-based oxidative stress nanoamplifier with ROS generation and GSH depletion for antitumor therapy.
用于抗肿瘤治疗的具有活性氧生成和谷胱甘肽消耗功能的肿瘤靶向透明质酸基氧化应激纳米放大器
Int J Biol Macromol. 2022 May 15;207:771-783. doi: 10.1016/j.ijbiomac.2022.03.139. Epub 2022 Mar 26.
4
Fabrication of Versatile Hollow Metal-Organic Framework Nanoplatforms for Folate-Targeted and Combined Cancer Imaging and Therapy.多功能中空金属有机骨架纳米平台的构建用于叶酸靶向和联合癌症成像与治疗。
ACS Appl Bio Mater. 2021 Aug 16;4(8):6417-6429. doi: 10.1021/acsabm.1c00603. Epub 2021 Jul 26.
5
Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.功能化聚多巴胺纳米粒口服递 Gambogenic 酸用于靶向肿瘤治疗。
Mol Pharm. 2021 Mar 1;18(3):1470-1479. doi: 10.1021/acs.molpharmaceut.1c00030. Epub 2021 Feb 14.
6
Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.层状功能化脂质体的口服药物传递的分子设计。
ACS Appl Mater Interfaces. 2020 Sep 30;12(39):43341-43351. doi: 10.1021/acsami.0c13504. Epub 2020 Sep 21.
7
Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.靶向细胞外囊泡包裹的 erastin 诱导三阴性乳腺癌细胞发生铁死亡。
Cancer Sci. 2019 Oct;110(10):3173-3182. doi: 10.1111/cas.14181. Epub 2019 Oct 3.
8
Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model.咪唑酮类化合物 Erastin 诱导铁死亡并减缓小鼠淋巴瘤模型中的肿瘤生长。
Cell Chem Biol. 2019 May 16;26(5):623-633.e9. doi: 10.1016/j.chembiol.2019.01.008. Epub 2019 Feb 21.
9
Adapting liposomes for oral drug delivery.使脂质体适用于口服药物递送。
Acta Pharm Sin B. 2019 Jan;9(1):36-48. doi: 10.1016/j.apsb.2018.06.005. Epub 2018 Jun 20.
10
Liposomal Formulations in Clinical Use: An Updated Review.临床应用中的脂质体制剂:最新综述。
Pharmaceutics. 2017 Mar 27;9(2):12. doi: 10.3390/pharmaceutics9020012.